Vol 3 Issue 8

CELL AND GENE THERAPY INSIGHTS

August 2017 Issue

Vol 3 Issue 8

Download PDF

Featuring

Issue Spotlight: Automation of Cell & Gene Therapy Manufacturing: from Vein to Vein
Other articles
Webinar

SPOTLIGHT

Automation of Cell & Gene Therapy Manufacturing: from Vein to Vein
Qasim Rafiq
Guest Editor:
Qasim Rafiq, Associate Professor of Cell & Gene Therapy Bioprocess Engineering at University College London

Editorial

Automation: systems thinking shows the value of manufacturing technology & those who can integrate product & process development

Automation: systems thinking shows the value of manufacturing technology & those who can integrate product & process development

David Williams
27 October 2017
Read

Research Article

Automated, spinning membrane filtration for preparation of mobilized leukapheresis products for CD34+ cell selection

Automated, spinning membrane filtration for preparation of mobilized leukapheresis products for CD34+ cell selection

Alaina Schlinker
30 October 2017
Read

Expert Insight

Advances in automation for the production of clinical-grade mesenchymal stromal cells: the AUTOSTEM robotic platform

Advances in automation for the production of clinical-grade mesenchymal stromal cells: the AUTOSTEM robotic platform

J Ochs, F Barry, R Schmitt et al.
21 November 2017
Read
Benefits of automation for pluripotent stem cell therapies, disease modeling & drug discovery

Benefits of automation for pluripotent stem cell therapies, disease modeling & drug discovery

Maciej S Daniszewski, Alice Pébay, Duncan E Crombie
27 October 2017
Read

Innovator Insight

Critically Evaluating the Benefits of Automation in Commercial-Scale Manufacture

Critically Evaluating the Benefits of Automation in Commercial-Scale Manufacture

Nina Bauer
30 October 2017
Read
Understanding the Critical Impact of Logistics on Scale-Up & Commercialization

Understanding the Critical Impact of Logistics on Scale-Up & Commercialization

Sam Herbert
17 October 2017
Read

Interview

The Evolving Role of Automation in CAR-T Cell Commercialization

The Evolving Role of Automation in CAR-T Cell Commercialization

Andrew Kaiser
27 October 2017
Read
Automated Manufacturing of Dendritic Cell Therapies: Progress & Challenges

Automated Manufacturing of Dendritic Cell Therapies: Progress & Challenges

Shashi Murthy
27 October 2017
Read
Automation in the translation of an autologous cell therapy from lab to commercial scale

Automation in the translation of an autologous cell therapy from lab to commercial scale

Rodney Rietze
27 October 2017
Read
Advances in automated analytical tools for cell therapy manufacturing

Advances in automated analytical tools for cell therapy manufacturing

Christopher Wiwi
27 October 2017
Read

Journal articles

Expert Insight

An alternative to patents: can DNA be protected by copyright and design right law?

An alternative to patents: can DNA be protected by copyright and design right law?

Beatriz San Martin, Heidi Hurdle
19 October 2017
Read

Commercial Insights

Cell & Gene Therapy Commercial Insight – September 2017

Cell & Gene Therapy Commercial Insight – September 2017

Mark Curtis, Richard Philipson
18 October 2017
Read

Webinars